# Atropine Sulfate

NDC: 63323-580
Generic name: Atropine Sulfate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: ENDOTRACHEAL, INTRAMEDULLARY, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20170123

FDA application: NDA209260

## Active ingredients

- ATROPINE SULFATE: .4 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-580"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-580
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=310c8a74-ea24-4357-8099-81e394b1634e